HERMS supports pharmaceutical, biotechnology, medical device and healthcare organisations across the whole life sciences value chain in the UAE, Saudi Arabia and the wider GCC, not regulatory affairs alone. HERMS software solutions cover regulatory intelligence, registration assessment, pharmacovigilance and patient safety, tender intelligence, promotional compliance, health logistics, clinical development, medical affairs, manufacturing and bioprocess, formulation, asset valuation and pipeline intelligence.
Discover the HERMS life sciences platform and our regulatory affairs expertise.
Regulatory intelligence and registration assessment
RULEXIS, SYNCRA and REGAXIS support regulatory intelligence and registration assessment for GCC markets: regulatory change monitoring, requirement mapping and evidence traceability. Read our guide to pharmaceutical product registration in the UAE.
Pharmacovigilance and patient safety
VIGILIX is the HERMS patient-safety solution, addressing unresolved findings, missed interventions and preventable harm. See pharmacovigilance obligations for GCC marketing authorisation holders and ICSR processing challenges.
Tender intelligence for UAE healthcare procurement
TENDERIX is the HERMS tender-intelligence module for UAE healthcare tenders, covering tender discovery, authorities, eligibility rules and bid preparation.
Promotional compliance and medical, legal and regulatory review
KLYRA supports promotional compliance and MLR review aligned with SFDA requirements.
Health logistics and supply chain
ARQON is the HERMS GCC health-logistics command solution for supply visibility and risk management.
Clinical development, medical affairs and clinical trials
EXIRIX addresses clinical development and VESTIGA addresses medical affairs and clinical trials intelligence.
Manufacturing transfer, bioprocess and formulation
SYNTRIX addresses manufacturing transfer and bioprocess intelligence, and VESTIGO addresses formulation and drug delivery.
Asset valuation, forecasting and pipeline intelligence
CAPNEXIS supports drug asset valuation, revenue forecasting and pipeline intelligence for market access and launch planning.
Cell and gene therapy intelligence
GENIX and CELLIX provide gene therapy and gene editing intelligence and regulatory intelligence for GCC advanced and biological healthcare products. Read about cell and gene therapy readiness in the GCC.